Literature DB >> 20412992

The Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) initiative: a country-driven, multi-partner program to support evidence-based decision making.

Kamel Senouci1, Julia Blau, Batmunkh Nyambat, Papa Coumba Faye, Lara Gautier, Alfred Da Silva, Michael O Favorov, John D Clemens, Philippe Stoeckel, Brad D Gessner.   

Abstract

Multiple health priorities, limited human resources and logistical capacities, as well as expensive vaccines with limited funds available increase the need for evidence-based decision making in immunization programs. The aim of the Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) Initiative is to support countries in the establishment or strengthening of National Immunization Technical Advisory Groups (NITAGs) that provide recommendations on immunization policies and programs (e.g., vaccination schedules, improvements of routine immunization coverage, new vaccine introduction, etc.). SIVAC, a program funded by the Bill & Melinda Gates Foundation, is based on a country-driven, step-by-step process that ensures its support is tailored to country needs and emphasizes NITAG sustainability. SIVAC supports countries by reinforcing the capacities of the NITAG scientific and technical secretariat and by providing specific support activities established in consultation with the country and other international partners. Additionally, SIVAC and partners have built an electronic platform, the NITAG Resource Center, that provides information, tools, and briefings to NITAGs and the immunization community.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20412992     DOI: 10.1016/j.vaccine.2010.02.028

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

2.  Moroccan National Immunization Technical Advisory Group: a valuable asset for the national immunization program and the immunization agenda in the EMRO region.

Authors:  Imane Jroundi; Mohammed Benazzouz; Abdel Hakim Yahyane; Moulay Tahar Alaoui; Nathalie El Omeiri
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

3.  Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making.

Authors:  William A Wells; Alan Brooks
Journal:  Health Res Policy Syst       Date:  2011-03-31

4.  Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.

Authors:  Raymond Hutubessy; Ana Maria Henao; Pem Namgyal; Vasee Moorthy; Joachim Hombach
Journal:  BMC Med       Date:  2011-05-12       Impact factor: 8.775

5.  National, Regional and Global Certification Bodies for Polio Eradication: A Framework for Verifying Measles Elimination.

Authors:  S Deblina Datta; Rudolf H Tangermann; Susan Reef; W William Schluter; Anthony Adams
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

6.  The Role of National Immunization Technical Advisory Groups (NITAGs) in the Introduction of Inactivated Polio Vaccine: Experience of the Indonesia and Uganda NITAGs.

Authors:  Antoinette Ba-Nguz; Alex Adjagba; Toto Wisnu Hendrarto; Nelson K Sewankambo; Celia Nalwadda; Annette Kisakye
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

7.  Strengthening and sustainability of national immunization technical advisory groups (NITAGs) globally: Lessons and recommendations from the founding meeting of the global NITAG network.

Authors:  Alex Adjagba; Noni E MacDonald; Inmaculada Ortega-Pérez; Philippe Duclos
Journal:  Vaccine       Date:  2017-04-26       Impact factor: 3.641

8.  Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts.

Authors:  Mark Jit; Carol Levin; Marc Brisson; Ann Levin; Stephen Resch; Johannes Berkhof; Jane Kim; Raymond Hutubessy
Journal:  BMC Med       Date:  2013-01-30       Impact factor: 8.775

9.  The need for sustainability and alignment of future support for National Immunization Technical Advisory Groups (NITAGs) in low and middle-income countries.

Authors:  Natasha Howard; Sadie Bell; Helen Walls; Laurence Blanchard; Logan Brenzel; Mark Jit; Sandra Mounier-Jack
Journal:  Hum Vaccin Immunother       Date:  2018-03-26       Impact factor: 3.452

10.  Existence and functionality of national immunisation technical advisory groups in Africa from 2010 to 2016.

Authors:  Alison B Wiyeh; Evanson Z Sambala; Ntombenhle Ngcobo; Charles S Wiysonge
Journal:  Hum Vaccin Immunother       Date:  2018-06-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.